法国系统性硬化症相关间质性肺病流行病学、死亡率与医疗资源利用数据集

基于法国国家医疗数据库的SSc-ILD患者流行病学研究数据集,包含发病率、死亡率、医疗资源利用及费用数据。

NIAID Data Ecosystem
浏览 17
表格epidemiologycostpulmonary fibrosissclerodermasystemic sclerosis
Data_Sheet_1_Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in France.docx

基本信息

模态
表格
大小
0.000088297 GB
许可
CC BY 4.0
创建/更新时间
2026-10-08
版本
v1

资源简介

法国系统性硬化症相关间质性肺病流行病学、死亡率与医疗资源利用数据集

【一句话概览】

本数据集是 figshare 公开的结构化表格数据集,收录 1 个文件、合计 88.30 KB,主题涵盖 epidemiology、cost、pulmonary fibrosis、scleroderma、systemic sclerosis,可用于统计建模、特征工程与队列分析,CC BY 4.0 许可开放获取。

【数据集背景】

本数据集源站标题为《Data_Sheet_1_Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in France.docx》。配套论文《<p>Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease</p>》发表于 Clinical Epidemiology(2019),DOI:10.2147/CLEP.S191418。源站首次发布:2021-08-30。

【数据内容】

源站原始描述:Objectives: To investigate the clinical characteristics, epidemiology, survival estimates and healthcare resource utilization and associated costs in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD) in France. Methods: The French national administrative healthcare database, the Système National des Données de Santé (SNDS), includes data on 98.8% of the French population, including data relating to ambulatory care, hospitalizations and death. In our study, claims da…

中文译文(机器翻译,仅供快速理解,请以原文为准):目的:研究法国系统性硬化症相关间质性肺病(SSc-ILD)患者的临床特征、流行病学、生存估计以及医疗资源利用和相关费用。 方法:法国国家行政医疗数据库——国家健康数据系统(Système National des Données de Santé,SNDS)包含法国98.8%人口的数据,其中包括与门诊诊疗、住院和死亡相关的数据。在本研究中,我们使用SNDS的医保报销数据来识别2010年至2017年间的成人SSc-ILD患者。我们收集了临床特征、发病率、患病率、生存估计、医疗资源使用和费用数据。 结果:共识别出3,333例SSc-ILD患者,其中76%为女性。患者平均年龄[标准差(SD)]为60.6(14.4)岁,平均(SD)个体研究持续时间为3.9(2.7)年。2016年,估计的总发病率和患病率分别为0.69/100,000人和5.70/100,000人。使用Kaplan–Meier估计的患者总生存率在1年、3年和8年时分别为93%、82%和55%。在研究期间,98.7%的患者有≥1次住院,22.3%的患者入住重症监护病房。每例SSc-ILD患者的年均总医疗费用为25,753欧元,其中21,539欧元与住院相关。 结论:这项大型真实世界纵向研究为了解法国SSc-ILD的流行病学提供了重要见解,并表明该病与高死亡率、高医疗资源利用和高费用相关。SSc-ILD对患者和医疗服务均造成沉重负担。 临床试验注册:www.ClinicalTri

【数据结构与技术规格】

文件数 1 个,合计 88.30 KB。Data_Sheet_1_Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in Fr.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,88.30 KB。数据集 DOI:10.3389/fmed.2021.699532.s001。

【主题与分类】

源站学科分类:Radiology and Organ Imaging、Foetal Development and Medicine、Obstetrics and Gynaecology、Primary Health Care、Medical and Health Sciences not elsewhere classified、Dermatology。主题标签:epidemiology、cost、pulmonary fibrosis、scleroderma、systemic sclerosis。

【适用方向】

结构化表格数据可直接用于统计建模、特征工程与队列分析。

【获取与许可】

源站页面:https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Epidemiology_Mortality_and_Healthcare_Resource_Utilization_Associated_With_Systemic_Sclerosis-Associated_Interstitial_Lung_Disease_in_France_docx/16531905

使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。

规范引用:Cottin, Vincent; Larrieu, Sophie; Boussel, Loic; Si-Mohamed, Salim; Bazin, Fabienne; Marque, Sébastien; et al. (2021). Data_Sheet_1_Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in France.docx. Frontiers. Dataset

【使用注意】

· 源站最后修改于 2023-06-10,引用时请注意版本时效。

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务(收技术服务费,非数据销售)

暂未开放

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "Data_Sheet_1_Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in Fr.docx" "https://ndownloader.figshare.com/files/30568701"

文件清单

  • Data_Sheet_1_Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in Fr.docx(88.30 KB)

文件总体积 88.30 KB(源站 API 实测)。

数据加载示例(图像类)

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Objectives: To investigate the clinical characteristics, epidemiology, survival estimates and healthcare resource utilization and associated costs in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD) in France.
Methods: The French national administrative healthcare database, the Système National des Données de Santé (SNDS), includes data on 98.8% of the French population, including data relating to ambulatory care, hospitalizations and death. In our study, claims data from the SNDS were used to identify adult patients with SSc-ILD between 2010 and 2017. We collected data on clinical features, incidence, prevalence, survival estimates, healthcare resource use and costs.
Results: In total, 3,333 patients with SSc-ILD were identified, 76% of whom were female. Patients had a mean age [standard deviation (SD)] of 60.6 (14.4) years and a mean (SD) individual study duration of 3.9 (2.7) years. In 2016, the estimated overall incidence and prevalence were 0.69/100,000 individuals and 5.70/100,000 individuals, respectively. The overall survival estimates of patients using Kaplan–Meier estimation were 93, 82, and 55% at 1, 3, and 8 years, respectively. During the study, 98.7% of patients had ≥1 hospitalization and 22.3% of patients were hospitalized in an intensive care unit. The total annual mean healthcare cost per patient with SSc-ILD was €25,753, of which €21,539 was related to hospitalizations.
Conclusions: This large, real-world longitudinal study provides important insights into the epidemiology of SSc-ILD in France and shows that the disease is associated with high mortality, healthcare resource utilization and costs. SSc-ILD represents a high burden on both patients and healthcare services.
Clinical Trial Registration:www.ClinicalTrials.gov, identifier: NCT03858842.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/fmed.2021.699532.s001(source: https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Epidemiology_Mortality_and_Healthcare_Resource_Utilization_Associated_With_Systemic_Sclerosis-Associated_Interstitial_Lung_Disease_in_France_docx/16531905)。

数据缺失?

依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。

⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。

获取专属数据定制方案